Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
<i>Pseudomonas aeruginosa</i> is a pathogen often encountered in a healthcare setting. It has consistently ranked among the most frequent pathogens seen in nosocomial infections, particularly bloodstream and respiratory tract infections. Aside from having intrinsic resistance to many ant...
Main Authors: | Johnny Zakhour, Sima L. Sharara, Joya-Rita Hindy, Sara F. Haddad, Souha S. Kanj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/10/1432 |
Similar Items
-
The Hazards of Probiotics on Gut-Derived <i>Pseudomonas aeruginosa</i> Sepsis in Mice Undergoing Chemotherapy
by: Fu-Chen Huang, et al.
Published: (2024-01-01) -
Determination of Antimicrobial Resistance and the Impact of Imipenem + Cilastatin Synergy with Tetracycline in <i>Pseudomonas aeruginosa</i> Isolates from Sepsis
by: Telma de Sousa, et al.
Published: (2023-11-01) -
Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with <i>Pseudomonas aeruginosa</i> Sepsis
by: Ewelina Piktel, et al.
Published: (2020-04-01) -
Gingival Necrosis Related to Sepsis-Induced Agranulocytosis Due to <i>Pseudomonas aeruginosa</i> Bacteraemia: A Case Report
by: Jia Ying Tan, et al.
Published: (2024-02-01) -
BSA Hydrogel Beads Functionalized with a Specific Aptamer Library for Capturing <i>Pseudomonas aeruginosa</i> in Serum and Blood
by: Markus Krämer, et al.
Published: (2021-10-01)